申请人:Teijin Limited
公开号:US05614520A1
公开(公告)日:1997-03-25
Pharmaceutical compositions for treating gout or hyperuricemia and containing a new categorized compound, i.e. 2-arylthiazole derivatives, as an active ingredient, are provided. The 2-arylthiazole derivatives in the present invention are represented by the following formula (I): ##STR1## wherein Ar is an unsubstituted or substituted pyridyl, thienyl, furyl, naphthyl or phenyl group; X is a hydrogen atom, alkyl group or carboxyl group which may be protected, and Y is a hydrogen atom, alkyl group, or a hydroxyl or carbonyl group which may be protected. Furthermore, novel compounds included in the 2-arylthiazole derivatives and pharmaceutically acceptable salts thereof are provided.
提供用于治疗痛风或高尿酸血症的药物组合物,含有一种新分类化合物,即2-芳基噻唑衍生物,作为活性成分。本发明中的2-芳基噻唑衍生物由以下式(I)表示:其中Ar是未取代或取代的吡啶基、噻吩基、呋喃基、萘基或苯基;X是氢原子、烷基或可保护的羧基,Y是氢原子、烷基或可保护的羟基或羰基。此外,提供了包括在2-芳基噻唑衍生物中的新化合物及其药用盐。